This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Essential Hypertension
and you are
between 20 and 45
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.

Provided treatments

  • Drug: Fimasartan
  • Drug: Hydrochlorothiazide
Tris trial is registered with FDA with number: NCT00923533. The sponsor of the trial is Boryung Pharmaceutical Co., Ltd and it is looking for 34 volunteers for the current phase.
Official trial title:
An Open-label, Multiple-dosing, Crossover, and Parallel Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers